NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Catalyst OrthoScience Inc.

Catalyst OrthoScience Inc.

Private
Naples, FloridaHealthcare & Life Scienceshttps://catalystortho.com/

Last Round

Series G

Oct 22, 2025

Est. Valuation

$117.5M

Total Funding Raised

$72.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Catalyst OrthoScience Inc. is a medical device company that develops and markets shoulder replacement systems designed to make orthopedic surgery less invasive and more efficient.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

shoulder arthroplastyorthopedic implantsshoulder replacementpatient-specific instrumentationPSIsurgical guidespre-operative planningreverse shoulder systemanatomic shoulder systemambulatory surgery centersASCsmedical deviceortho techmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Catalyst OrthoScience Inc. Comparables

Compare Catalyst OrthoScience Inc. with similar companies based on industry and business-model similarity.

Catalyst OrthoScience Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Enovis Corp
80%
Exactech
79%
Johnson & Johnson
79%

Catalyst OrthoScience Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series GOct 22, 2025
VC RoundJul 31, 2025
DebtSep 10, 2024
Series DOct 6, 2021
Series CMay 14, 2019
Series B
Nov 29, 2017

Key People

Founding team and executive leadership

Steven Goldberg

Founder And Chief Medical Officer

Founding Team

Carl O'Connell

President And CEO

Executive Team

Robert Richter

Chief Financial Officer

Executive Team

Catalyst OrthoScience Inc. Investors

Notable investors and investment history

Catalyst OrthoScience Inc. investors
InvestorRounds
Mutual Capital PartnersDebt, Series G, Series D
River Cities CapitalDebt
RC CapitalDebt, Series C, Series D, Series G
Bridge BankDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2026

    Received 510(k) clearance for Archer Patient-Specific Instrumentation.

  • Oct 22, 2025

    $15M raised in debt financing.

Catalyst OrthoScience Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Catalyst OrthoScience Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Catalyst OrthoScience Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNaples, Florida
Employee Range52
Year Founded2014
Last FundingOct 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.